tirzepatide nano microneedle patch Luhaka® NIDDK-Tirzepatide LERCEA® SMGT-GLP-1 Tirzepatide & Collagen

Doses up to 600 mg were generally well-tolerated with no clinically significant abnormalities in blood pressure or heart rate, no observed skin pigmentation, and no significant changes to adrenal, urinary or hematology panels

Challenges and opportunities in delivering oral peptides and proteins

GLP-1 drugs like Ozempic and Mounjaro can be a wild ride users may experience dramatic weight loss and a sharp drop in appetite but also fierce bouts of nausea, vomiting or diarrhea

It's not built for one specific goal it's built to give your body a full reset

Instruct patients to inform healthcare providers prior to any planned surgeries or procedures if they are taking OZEMPIC [see Warnings and Precautions (5.10)]